Stockreport

Biogen Rallies After Spinraza, Multiple Sclerosis Revenue Come In Light [Investor's Business Daily]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Related news 4/23/2018 Merck popped to a three-month high Monday after Goldman Sachs suggested its cancer drug, Keytruda, could be a $16 billion... Ionis Shares Jump [Read more]